Virax Biolabs Group Limited (VRAX)

$0.78 -0.01 (-0.78%)
Market Cap 3.40M
Revenue (ttm) 10,000.00
Net Income (ttm) -6.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -60,600.00%
Debt to Equity Ratio 0.01
Volume 23,500
Avg Vol 100,992
Day's Range N/A - N/A
Shares Out 4.34M
Stochastic %K 14%
Beta 1.66
Analysts Strong Sell
Price Target $3.00

Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 7788 7414
Address:
BioCity Glasgow, Bo’Ness Road Newhouse, Lanarkshire, United Kingdom
King_Foster
King_Foster Aug. 8 at 7:22 PM
$VRAX Don’t listen to @ucla44life, he's just mad at me because I stole his girl back in high school and he still isn't over it.
0 · Reply
Xenocyde
Xenocyde Aug. 8 at 6:55 PM
$VRAX where did you go missed those red days. almost had to put out a wellness check. So what’s the date if it’s inbound?
0 · Reply
ucla44life
ucla44life Aug. 8 at 6:07 PM
$VRAX DELISTING INBOUND!!!
0 · Reply
ucla44life
ucla44life Aug. 8 at 6:07 PM
$VRAX Just a reminder this is a pump & dump SCAM...just look at the chart :-) only ones bullish are bag holders from the $6-$7 range....desperation is bad investing, JUST FACTS!!!
0 · Reply
WKUK
WKUK Aug. 8 at 11:50 AM
$VRAX I also want to remined everyone that Virax will be presenting at an Immunology Conference this month.
0 · Reply
WKUK
WKUK Aug. 8 at 11:49 AM
$VRAX
0 · Reply
BuyNow_SellLater
BuyNow_SellLater Aug. 7 at 7:40 PM
$VRAX hello my old friend, are you ready to move again?
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Aug. 7 at 12:26 PM
$VRAX To regain compliance with the minimum bid price requirement, the Company's common stock, par value $0.001 per share, is required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days.
0 · Reply
WKUK
WKUK Aug. 7 at 11:20 AM
$VRAX I appreciate your posts in here. There is not many willing to stick their necks out for this stock anymore. Watching the dark pool volume over the last two days has shown me there is clearly something or someone accumulating shares in the .77-.80 range. Lots of small orders testing and slowly eating up the liquidity in that range.
1 · Reply
Love_To_Learn
Love_To_Learn Aug. 7 at 9:56 AM
$VRAX need u shortly
0 · Reply
Latest News on VRAX
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Jul 29, 2025, 7:35 AM EDT - 12 days ago

Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Jul 18, 2025, 4:15 PM EDT - 23 days ago

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Mar 31, 2025, 2:57 PM EDT - 4 months ago

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Mar 18, 2025, 7:30 AM EDT - 5 months ago

Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Mar 13, 2025, 7:30 AM EDT - 5 months ago

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Mar 5, 2025, 7:30 AM EST - 5 months ago

Virax Biolabs to Present at 19th World Immune Regulation Meeting

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Feb 25, 2025, 7:00 AM EST - 5 months ago

Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 7 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

COSM

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 7 months ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

COSM

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dec 17, 2024, 7:30 AM EST - 8 months ago

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Dec 10, 2024, 7:30 AM EST - 8 months ago

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Oct 23, 2024, 7:30 AM EDT - 10 months ago

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

Sep 16, 2024, 8:30 AM EDT - 11 months ago

Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar

COSM

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Sep 16, 2024, 8:30 AM EDT - 11 months ago

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

COSM

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Sep 9, 2024, 8:00 AM EDT - 11 months ago

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

Virax Biolabs to Participate at 7th European Congress of Immunology

Aug 29, 2024, 9:03 AM EDT - 1 year ago

Virax Biolabs to Participate at 7th European Congress of Immunology

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Aug 28, 2024, 2:18 PM EDT - 1 year ago

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Aug 23, 2024, 4:09 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Aug 21, 2024, 9:30 PM EDT - 1 year ago

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

Aug 21, 2024, 10:20 AM EDT - 1 year ago

Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits

COSM

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Apr 25, 2024, 8:00 AM EDT - 1 year ago

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Apr 16, 2024, 7:30 AM EDT - 1 year ago

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Dec 21, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Dec 14, 2023, 7:30 AM EST - 1 year ago

Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Sep 12, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Sep 1, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Jul 18, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

May 4, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Apr 19, 2023, 7:30 AM EDT - 2 years ago

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 10, 2023, 5:17 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Mar 8, 2023, 8:55 AM EST - 2 years ago

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Mar 7, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

Feb 7, 2023, 9:15 AM EST - 2 years ago

Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests

COSM

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Feb 7, 2023, 8:30 AM EST - 2 years ago

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

COSM

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Feb 6, 2023, 4:05 PM EST - 2 years ago

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Jan 4, 2023, 7:30 AM EST - 2 years ago

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Dec 6, 2022, 7:30 AM EST - 2 years ago

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Nov 15, 2022, 7:30 AM EST - 2 years ago

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Nov 8, 2022, 4:30 PM EST - 2 years ago

Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Nov 4, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Oct 26, 2022, 7:30 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Sep 22, 2022, 8:07 AM EDT - 3 years ago

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

COSM

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Sep 12, 2022, 7:00 AM EDT - 3 years ago

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Sep 6, 2022, 4:00 PM EDT - 3 years ago

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Aug 16, 2022, 7:31 AM EDT - 3 years ago

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Jul 26, 2022, 8:00 AM EDT - 3 years ago

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Investors May Want to Follow Progress of VC-Backed Medtechs

Jul 25, 2022, 6:19 PM EDT - 3 years ago

Investors May Want to Follow Progress of VC-Backed Medtechs

BHC BLCO MDT MHUA TNON

King_Foster
King_Foster Aug. 8 at 7:22 PM
$VRAX Don’t listen to @ucla44life, he's just mad at me because I stole his girl back in high school and he still isn't over it.
0 · Reply
Xenocyde
Xenocyde Aug. 8 at 6:55 PM
$VRAX where did you go missed those red days. almost had to put out a wellness check. So what’s the date if it’s inbound?
0 · Reply
ucla44life
ucla44life Aug. 8 at 6:07 PM
$VRAX DELISTING INBOUND!!!
0 · Reply
ucla44life
ucla44life Aug. 8 at 6:07 PM
$VRAX Just a reminder this is a pump & dump SCAM...just look at the chart :-) only ones bullish are bag holders from the $6-$7 range....desperation is bad investing, JUST FACTS!!!
0 · Reply
WKUK
WKUK Aug. 8 at 11:50 AM
$VRAX I also want to remined everyone that Virax will be presenting at an Immunology Conference this month.
0 · Reply
WKUK
WKUK Aug. 8 at 11:49 AM
$VRAX
0 · Reply
BuyNow_SellLater
BuyNow_SellLater Aug. 7 at 7:40 PM
$VRAX hello my old friend, are you ready to move again?
0 · Reply
TrdrBuckNKy
TrdrBuckNKy Aug. 7 at 12:26 PM
$VRAX To regain compliance with the minimum bid price requirement, the Company's common stock, par value $0.001 per share, is required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days.
0 · Reply
WKUK
WKUK Aug. 7 at 11:20 AM
$VRAX I appreciate your posts in here. There is not many willing to stick their necks out for this stock anymore. Watching the dark pool volume over the last two days has shown me there is clearly something or someone accumulating shares in the .77-.80 range. Lots of small orders testing and slowly eating up the liquidity in that range.
1 · Reply
Love_To_Learn
Love_To_Learn Aug. 7 at 9:56 AM
$VRAX need u shortly
0 · Reply
Paulfrench
Paulfrench Aug. 6 at 7:41 PM
$VRAX here we are...money time 😬🤞
0 · Reply
WKUK
WKUK Aug. 5 at 1:35 PM
$VRAX Interview given by Nigel McCracken to the-scientist.com on April 25, 2025. - ViraxImmune helps assess an individual's immune profile, which is crucial for identifying abnormal immune responses that may lead to autoimmunity. - ImmuneSelect is geared toward selecting optimal immune biomarkers for diagnostics and therapeutic development. Strategic Relevance: - Autoimmune diseases are notoriously difficult to diagnose and treat due to their complex and individualized nature. - VRAX’s platforms aim to personalize immune profiling, which could lead to earlier detection and more targeted therapies. - Market Positioning: By aligning their technology with cutting-edge autoimmune research, VRAX is positioning itself as a key player in precision immunology, which has applications in infectious disease, cancer, and chronic inflammatory conditions. https://www.the-scientist.com/a-double-edged-sword-autoimmunity-and-pathogenesis-73063
0 · Reply
WKUK
WKUK Aug. 5 at 12:23 PM
$VRAX Starting to get more chatter https://www.linkedin.com/posts/virax-biolabs_immunology-research-lifescience-activity-7358449163765784578-96wa?utm_source=share&utm_medium=member_desktop&rcm=ACoAACZWlrQBb_H1Ld7bBDZJUSQ7BnewaFbSN_c
0 · Reply
WKUK
WKUK Aug. 4 at 8:52 PM
$VRAX The fact is, you've been here following this stock as much as the people invested in it, while at the same time claiming not to be a short (lol). In your own words, you are here because you love outing scammers. Is $VRAX the only stock on the market that is a scam? Why don't you go do the same to the many other stock scams? Is there something special about this one stock? You seem to post in this board just as much as you do all the stocks your bullish on. Strange. You also really like spamming multiple posts with bearish tags. Multiple posts with nothing new to add, just the same BS over and over again.
0 · Reply
Xenocyde
Xenocyde Aug. 4 at 8:48 PM
$VRAX
0 · Reply
ucla44life
ucla44life Aug. 4 at 8:05 PM
$VRAX to those that listened a long time ago ($4+)...you're welcome for my supreme market knowledge and control ;-) to those that didn't, keep losing and keep saying you're bullish for no reason whatsoever.
0 · Reply
ucla44life
ucla44life Aug. 4 at 7:53 PM
$VRAX THE FACT IS, I'VE BEEN HERE SINCE OVER $4 TELLING YOU IT WAS A P&D SCAM..... AND SHOCKINGLY THE STOCK HAS ONLY GONE DOWN TO IT'S CURRENT LEVEL SINCE THEN, SO OBVIOUSLY SOMEONE IS RIGHT :-) AND THE BAG HOLDERS ARE COMPLETELY WRONG DURRRRRRRRRRRRR LOOKS LIKE THE MARKET AGREES AND CONTINUES TO AGREE...FYI ROOKIE, JUST BECAUSE A COMPANY HAS BEEN AROUND FOR A LONG TIME DOESN'T MEAN IT'S LEGIT. ENJOY THE CAPS, ENJOY THE DURRRR'S AND THE WEEEEEEEEEEEEEEEEEEEE'S THE FACT IS YOU KEEP LOSING AND I CONTINUE TO BE RIGHT AS ALWAYS :-) ENJOY THE PAIN TRAIN WEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
0 · Reply
WKUK
WKUK Aug. 4 at 4:32 PM
$VRAX SCAM COMPANY has one of their customers sharing their product. Not only that but it's being shared by a SCAM company out of Germany that was founded in 1968.
0 · Reply
Xenocyde
Xenocyde Aug. 4 at 4:32 PM
$VRAX you know if you capitalize everything your message gets across better and you look like a totally sane person. Wait did he just say this is one of the biggest pump and dump scams in the otc?? Can’t even get simple facts straight. Def listen to this guy.
1 · Reply
WKUK
WKUK Aug. 4 at 4:17 PM
$VRAX As I thought. You've got nothing.
0 · Reply
ucla44life
ucla44life Aug. 4 at 4:15 PM
$VRAX ONE OF THE BIGGEST PUMP AND DUMP SCAMS IN THE OTC....ALL THESE BAG HOLLDERS LEARNING THE HARD WAY...SHOULDA LISTENED FROM WHEN I WAS DESTROYING THIS AT $4+....DON'T WANT TO LISTEN TO FACTS, FINE, KEEP LOSING THEN!!! CAN'T HELP STUPID YOU LOSE, WHOMP, WHOMP!!!
0 · Reply
WKUK
WKUK Aug. 4 at 3:46 PM
$VRAX You ever going to show some sort of evidence that this is a scam run by a "CON ARTIST". I like how you capitalized it so it must be true. Where is any of your research?
3 · Reply